ERBB2 and brain neoplasm: Repeated dosing of HER2-targeted CAR T-cells via a central nervous system (CNS) catheter has also been undertaken in children and young adults with relapsed refractory brain tumours [31], highlighting the potential of this approach to trigger a local inflammatory response.